India's Aurobindo Pharma is reportedly in talks with Novartis and Teva over the sale of a strategic investment in the antibiotics manufacturer. No one at any of the companies was talking, but Aurobindo's role in supplying low-cost generics to developing countries offers a tempting target for global pharma companies like Novartis and Teva. Report